Molina Competitors

MOH Stock

USD 135.35 8.64 6.82%

Molina Healthcare competes with DaVita HealthCare, Henry Schein, Globus Medical, HealthEquity, and Grifols SA; as well as few others. The company runs under Health Care Providers & Services sector within Health Care industry. Analyzing Molina Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Molina Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Molina Healthcare Correlation with its peers.

For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.

Molina Healthcare vs Avantor Correlation

Very weak diversification

The correlation between Molina Healthcare and AVTR is 0.53 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Molina Healthcare and AVTR in the same portfolio, assuming nothing else is changed.

Moving against Molina Stock

0.53	S00	Spire Healthcare	Pair Corr
0.32	X2S	Sinopharm Group	Pair Corr
0.32	MD	Mednax Inc Earnings Call This Week	Pair Corr

The Molina Healthcare's current Return On Equity is estimated to increase to 0.20, while Return On Tangible Assets are projected to decrease to 0.03. As of now, Molina Healthcare's Total Current Assets are increasing as compared to previous years. The Molina Healthcare's current Intangible Assets is estimated to increase to about 2.3 B, while Net Tangible Assets are projected to decrease to under 1.1 B.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
131.70	135.81	139.92

Details

Intrinsic

Valuation

Low	Real	High
121.82	143.42	147.53

Details

16 Analysts

Consensus

Low	Target	High
147.19	161.75	179.54

Details

Earnings

Estimates (0)

Low	Projected EPS	High
1.02	2.81	6.23

Details

Molina Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Molina Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Molina and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Molina Healthcare does not affect the price movement of the other competitor.

	DVA	HSIC	GMED	HQY	GRFS	BIO	HALO	ATR	MASI	AVTR
DVA		0.14	-0.43	-0.3	0.17	-0.38	0.49	0.59	-0.1	-0.66	DVA
HSIC	0.14		0.52	-0.61	0.64	-0.23	0.4	0.62	-0.5	0.06	HSIC
GMED	-0.43	0.52		-0.32	0.4	0.23	0.14	0.17	-0.13	0.49	GMED
HQY	-0.3	-0.61	-0.32		-0.65	0.61	-0.55	-0.75	0.51	0.32	HQY
GRFS	0.17	0.64	0.4	-0.65		-0.37	0.38	0.5	-0.63	-0.08	GRFS
BIO	-0.38	-0.23	0.23	0.61	-0.37		-0.26	-0.52	0.43	0.71	BIO
HALO	0.49	0.4	0.14	-0.55	0.38	-0.26		0.7	-0.13	-0.14	HALO
ATR	0.59	0.62	0.17	-0.75	0.5	-0.52	0.7		-0.4	-0.44	ATR
MASI	-0.1	-0.5	-0.13	0.51	-0.63	0.43	-0.13	-0.4		0.22	MASI
AVTR	-0.66	0.06	0.49	0.32	-0.08	0.71	-0.14	-0.44	0.22		AVTR
	DVA	HSIC	GMED	HQY	GRFS	BIO	HALO	ATR	MASI	AVTR

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

AVTR	+ 0.71	BIO
ATR	+ 0.7	HALO
GRFS	+ 0.64	HSIC
ATR	+ 0.62	HSIC
BIO	+ 0.61	HQY
ATR	+ 0.59	DVA

High negative correlations

ATR	- 0.75	HQY
AVTR	- 0.66	DVA
GRFS	- 0.65	HQY
MASI	- 0.63	GRFS
HQY	- 0.61	HSIC
HALO	- 0.55	HQY

Risk-Adjusted Indicators

There is a big difference between Molina Stock performing well and Molina Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Molina Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DVA	1.83	0.36	0.17	3.22	1.54	(2.50)	4.25	(3.23)	26.79
HSIC	1.20	0.05	0.03	0.12	1.45	(1.28)	2.43	(2.60)	7.52
GMED	1.26	(0.02)	(0.02)	0.04	1.26	(1.78)	3.63	(2.45)	7.49
HQY	1.64	(0.49)	0.00	(0.48)	0.00	0.00	2.51	(4.43)	12.83
GRFS	1.37	0.09	0.04	0.19	1.66	(1.39)	3.23	(3.28)	8.28
BIO	1.44	(0.32)	0.00	(0.23)	0.00	0.00	3.02	(2.88)	8.43
HALO	1.66	0.20	0.09	0.32	1.78	(1.77)	3.72	(2.90)	9.83
ATR	1.12	0.27	0.19	0.36	1.11	(1.38)	2.93	(1.51)	8.45
MASI	1.59	(0.19)	0.00	(0.21)	0.00	0.00	3.02	(2.71)	10.00
AVTR	1.88	(0.40)	0.00	(0.20)	0.00	0.00	3.75	(4.39)	21.90

Cross Equities Net Income Analysis

Compare Molina Healthcare and related stocks such as DaVita HealthCare, Henry Schein, and Globus Medical Net Income Over Time

Select Fundamental

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
DVA	4.9 M	478 M	536 M	633.4 M	723.1 M	269.7 M	879.9 M	663.6 M	159.4 M	811 M	773.6 M	978.5 M	560.4 M	691.5 M	936.3 M	746.8 M	432.3 M
HSIC	(10.9 M)	367.7 M	388.1 M	444.1 M	466.1 M	479.1 M	506.8 M	406.3 M	535.9 M	508 M	402.2 M	623.9 M	538 M	416 M	390 M	448.5 M	301.7 M
GMED	48.7 M	60.8 M	73.8 M	68.6 M	92.5 M	112.8 M	104.3 M	107.3 M	156.5 M	155.2 M	102.3 M	149.2 M	190.2 M	122.9 M	103 M	118.4 M	117.1 M
HQY	11.2 M	11.2 M	11.2 M	1.2 M	10.2 M	16.6 M	26.4 M	47.4 M	73.9 M	39.7 M	8.8 M	(44.3 M)	(26.1 M)	55.7 M	96.7 M	111.2 M	116.8 M
GRFS	25.6 M	50.3 M	256.7 M	345.6 M	470.3 M	532.1 M	545.5 M	662.7 M	596.6 M	625.1 M	618.5 M	188.7 M	185 M	42.3 M	156.9 M	180.5 M	320.1 M
BIO	4.3 M	178.2 M	169.2 M	77.8 M	88.8 M	113.1 M	28.1 M	114.7 M	361 M	1.8 B	3.8 B	4.3 B	(3.6 B)	(637.3 M)	(1.8 B)	759.9 M	797.9 M
HALO	(39.7 K)	(19.8 M)	(53.6 M)	(83.5 M)	(68.4 M)	(32.2 M)	(103 M)	63 M	(80.3 M)	(72.2 M)	129.1 M	402.7 M	202.1 M	281.6 M	444.1 M	510.7 M	536.2 M
ATR	19.5 M	183.7 M	162.6 M	172 M	191.7 M	199.3 M	205.6 M	220 M	194.7 M	242.2 M	214 M	244.1 M	239.3 M	284.5 M	374.5 M	392.8 M	412.4 M
MASI	(6.5 M)	63.7 M	62.3 M	58.4 M	72.5 M	83.3 M	300.7 M	131.6 M	193.5 M	196.2 M	240.3 M	229.6 M	143.5 M	81.5 M	(304.9 M)	(350.6 M)	(333.1 M)
AVTR	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	21.6 M	(42.4 M)	(112.7 M)	(86.9 M)	37.8 M	116.6 M	572.6 M	686.5 M	321.1 M	711.5 M	(530.2 M)	(503.7 M)

Molina Healthcare and related stocks such as DaVita HealthCare, Henry Schein, and Globus Medical Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Molina Healthcare financial statement analysis. It represents the amount of money remaining after all of Molina Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Molina Healthcare Competitive Analysis

The better you understand Molina Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Molina Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Molina Healthcare's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	MOH	DVA	HSIC	GMED	HQY	GRFS	BIO	HALO	ATR	MASI
	6.82 135.35 Molina	0.68 148.95 DaVita	0.31 78.19 Henry	1.00 88.09 Globus	0.92 73.88 HealthEquity	0.43 9.32 Grifols	12.26 256.56 Bio	3.28 79.44 Halozyme	1.47 142.58 AptarGroup	2.11 130.15 Masimo
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Weak	Fair	Fair	Soft	Weakest	Fair	Weakest	Fair	Good	Weakest
Odds of Financial Distress (Probability Of Bankruptcy)	Tiny	Tiny	Tiny	Low	Tiny	Low	Low	Tiny	Tiny	Low
Current Valuation (Equity Enterprise Value)	Under Valued	Under Valued	Fairly Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Buy	Buy	Buy	Buy	Strong Buy	Buy	Buy	Buy	Strong Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Buy	Buy	Strong Hold	Hold	Strong Hold	Strong Hold	Strong Buy	Strong Buy	Strong Hold
Current Ratio	1.45	1.41	1.84	6.1	2.46	2.68	5.5	2.72	1.56	2.1
Net Asset	15.56 B	17.48 B	10.22 B	5.25 B	3.45 B	21.41 B	10.58 B	2.06 B	5.25 B	2.63 B
Profit Margin	0.0108	0.0547	0.0302	0.15	0.15	0.0496	0.29	0.48	0.1	-0.26
EBITDA	996 M	2.64 B	941 M	473.73 M	337.54 M	1.48 B	475.9 M	656.54 M	831.48 M	(158.7 M)
Operating Margin	-0.015	0.15	0.0614	0.22	0.25	0.2	0.0778	0.62	0.11	0.22
Current Valuation	2.22 B	22.2 B	12.53 B	11.4 B	7.03 B	17.7 B	6.59 B	9.86 B	10.17 B	7.42 B
Price To Book	1.6	21.63	2.74	2.65	2.96	1.03	0.93	17.95	3.39	8.82
Retained Earnings	3.6 B	(328.43 M)	3.77 B	1.15 B	209.27 M	156.92 M	8.18 B	359.87 M	2.64 B	1.49 B
Current Asset	177.56 M	544.53 M	1.03 B	544.8 M	143.05 M	3.09 B	466.61 M	171.77 M	519.72 M	299.14 M
Five Year Return	N/A	N/A	N/A	N/A	N/A	2.33	N/A	N/A	1.27	N/A
Beta	0.49	1.01	0.89	1.06	0.24	1.19	1.18	0.98	0.49	1.26
Number Of Employees	19 K	78 K	25 K	5.3 K	3.1 K	23.8 K	7.7 K	350	14 K	3.6 K
Shares Outstanding	51.5 M	66.85 M	117.72 M	111.41 M	86.16 M	258.22 M	21.91 M	117.6 M	64.38 M	53.71 M
Cash Flow From Operations	(535 M)	1.89 B	848 M	520.64 M	339.86 M	902.17 M	532.2 M	479.06 M	570 M	196.4 M
Annual Yield	N/A	N/A	N/A	N/A	N/A	0.0202	N/A	N/A	0.013	N/A
Total Debt	3.95 B	15.05 B	2.87 B	537.19 M	1.11 B	10.09 B	1.2 B	1.51 B	1.6 B	846.1 M
Return On Equity	0.11	0.65	0.0835	0.1	0.0901	0.0589	0.11	1.25	0.15	-0.21
Return On Asset	0.0314	0.0732	0.0423	0.0643	0.0544	0.0458	0.0138	0.21	0.0666	0.0318
Number Of Shares Shorted	2.89 M	6.77 M	5.17 M	4.12 M	3.64 M	6.88 M	819.07 K	13.52 M	1.23 M	4.11 M
Book Value Per Share	79.78	-9.5	28.35	32.68	24.93	7.61	276.32	4.29	41.56	15.08
Current Liabilities	102.94 M	292.6 M	423.33 M	82.69 M	12.11 M	1.05 B	208.93 M	62.46 M	411.89 M	132.63 M
Total Asset	15.56 B	17.48 B	10.22 B	5.25 B	3.45 B	21.41 B	10.58 B	2.06 B	5.25 B	2.63 B
Debt To Equity	0.79	5.68	0.29	0.002	0.54	1.14	0.16	4.28	0.63	0.83
Short Ratio	2.0	7.6	4.41	2.78	3.4	9.57	3.69	7.55	3.03	5.34
Target Price	161.75	151.71	78.14	107.17	119.13	12.53	328.0	78.0	161.43	183.75
Last Dividend Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	1.83	N/A
Shares Owned By Institutions	99.82	51.11	99.12	99.32	97.87	58.08	94.03	98.86	95.0	94.33
Market Capitalization	6.97 B	9.96 B	9.48 B	11.9 B	6.39 B	7.65 B	6.92 B	9.34 B	9.36 B	6.99 B
Price To Earning	26.49	11.43	17.39	73.16	525.29	14.34	2.9	60.08	28.95	35.69
Price To Earnings To Growth	0.5	0.6	1.76	1.73	0.66	0.23	1.19	-2.5	3.55	4.73
Price To Sales	0.16	0.73	0.73	4.3	4.95	1.02	2.68	7.52	2.48	3.2
Net Income	472 M	1.08 B	398 M	102.98 M	96.7 M	444 M	(61.6 M)	444.09 M	392.79 M	(304.9 M)
Earnings Per Share	8.92	9.5	3.17	3.09	2.18	0.63	27.86	4.74	5.89	-4.56
Shares Owned By Insiders	1.37	52.9	0.88	0.68	2.13	N/A	16.27	1.14	1.0	5.67
Revenue	45.43 B	13.64 B	12.67 B	2.52 B	1.2 B	7.21 B	2.58 B	1.02 B	3.78 B	2.09 B
Working Capital	5.07 B	916.37 M	1.18 B	1.32 B	321.43 M	3.57 B	2.56 B	946.24 M	727.12 M	608.1 M
Cash And Equivalents	4.25 B	676.44 M	123 M	408.01 M	176.89 M	549.09 M	488.1 M	209.36 M	402.42 M	218 M
Cash Per Share	135.88	3.98	0.91	4.1	2.09	0.4	62.03	1.52	1.91	4.15
Gross Profit	4.08 B	4.4 B	4.04 B	1.87 B	874.01 M	3 B	1.34 B	980.76 M	1.4 B	1.08 B
Day Typical Price	133.04	148.38	78.41	88.4	73.87	9.32	260.12	79.4	141.97	131.06
Accumulation Distribution	0.0517	0.0234	0.0265	0.0286	0.0258	0.0117	0.0799	0.0445	0.0176	0.0344
Market Facilitation Index	7.0	3.51	2.11	2.57	1.93	0.11	21.79	3.61	2.52	4.61
Daily Balance Of Power	1.234286	(0.29)	(0.11)	0.3385	0.3472	0.3636	(1.65)	0.6981	0.8214	(0.61)
Period Momentum Indicator	8.64	(1.02)	(0.24)	0.87	0.67	0.04	(35.86)	2.52	2.07	(2.81)
Rate Of Daily Change	1.07	0.99	1.0	1.01	1.01	1.0	0.88	1.03	1.01	0.98
Day Median Price	131.88	148.1	78.53	88.56	73.87	9.32	261.9	79.38	141.67	131.51
Price Action Indicator	7.79	0.34	(0.46)	(0.03)	0.35	0.015	(23.27)	1.31	1.95	(2.77)
Coefficient Of Variation	14158.24	873.96	1328.26	3839.86	(524.09)	1311.67	(931.00)	811.7	520.0	(1,463)
Mean Deviation	2.21	1.83	1.2	1.26	1.64	1.37	1.44	1.66	1.12	1.59
Jensen Alpha	0.0462	0.3578	0.0538	(0.02)	(0.49)	0.0882	(0.32)	0.2003	0.2658	(0.19)
Total Risk Alpha	(0.28)	0.1214	(0.01)	(0.09)	(0.61)	(0.01)	(0.43)	0.092	0.1914	(0.30)
Sortino Ratio	(0.01)	0.1717	0.0293	(0.02)	N/A	0.0368	N/A	0.0944	0.1941	N/A
Downside Variance	31.27	3.15	2.45	1.67	N/A	3.41	N/A	3.93	1.77	N/A
Standard Deviation	4.0	3.27	1.54	1.69	2.25	1.81	2.3	2.09	1.71	2.02
Kurtosis	25.66	24.98	0.0385	0.5465	4.38	0.354	11.15	(0.24)	7.2	1.37
Potential Upside	4.04	4.25	2.43	3.63	2.51	3.23	3.02	3.72	2.93	3.02
Treynor Ratio	(0.04)	3.22	0.1221	0.0359	(0.48)	0.1927	(0.23)	0.317	0.3643	(0.21)
Maximum Drawdown	30.76	26.79	7.52	7.49	12.83	8.28	8.43	9.83	8.45	10.0
Variance	15.98	10.72	2.36	2.85	5.07	3.28	5.27	4.35	2.91	4.1
Market Risk Adjusted Performance	(0.03)	3.23	0.1321	0.0459	(0.47)	0.2027	(0.22)	0.327	0.3743	(0.20)
Risk Adjusted Performance	0.0137	0.0999	0.0655	0.0262	(0.15)	0.0671	(0.08)	0.1055	0.1605	(0.05)
Skewness	(4.13)	3.99	(0.16)	0.7785	(1.49)	0.0239	(1.78)	0.1057	1.41	0.7948
Semi Deviation	5.48	1.54	1.45	1.26	N/A	1.66	N/A	1.78	1.11	N/A
Information Ratio	(0.01)	0.0931	0.0298	(0.02)	(0.22)	0.0376	(0.14)	0.0897	0.1513	(0.10)
Value At Risk	(3.38)	(3.23)	(2.60)	(2.45)	(4.43)	(3.28)	(2.88)	(2.90)	(1.51)	(2.71)
Expected Short fall	(1.94)	(2.50)	(1.28)	(1.78)	N/A	(1.39)	N/A	(1.77)	(1.38)	N/A
Downside Deviation	5.59	1.77	1.57	1.29	N/A	1.85	N/A	1.98	1.33	N/A
Semi Variance	30.08	2.38	2.1	1.58	N/A	2.76	N/A	3.17	1.22	N/A

Molina Healthcare Competition Performance Charts

Five steps to successful analysis of Molina Healthcare Competition

Molina Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Molina Healthcare in relation to its competition. Molina Healthcare's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Molina Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Molina Healthcare's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Molina Healthcare, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Molina Healthcare position

In addition to having Molina Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 47 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.

View All Next

Launch

When determining whether Molina Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molina Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molina Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molina Healthcare Stock:

How To Invest In Molina

Details

Is Molina Stock a good investment?

Details

What is Molina Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Molina Healthcare Correlation with its peers.

For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is there potential for Health Care Providers & Services market expansion? Will Molina introduce new products? Factors like these will boost the valuation of Molina Healthcare. Expected growth trajectory for Molina significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.73)

Earnings Share

8.92

Revenue Per Share

825.057

Quarterly Revenue Growth

0.071

Return On Assets

0.0314

Investors evaluate Molina Healthcare using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Molina Healthcare's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Molina Healthcare's market price to deviate significantly from intrinsic value.

Understanding that Molina Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Molina Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Molina Healthcare's market price signifies the transaction level at which participants voluntarily complete trades.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Molina Competitors

Molina Healthcare vs Avantor Correlation

Very weak diversification

Moving against Molina Stock

Specify up to 10 symbols:

Molina Healthcare Competition Correlation Matrix

High positive correlations

High negative correlations

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Molina Healthcare and related stocks such as DaVita HealthCare, Henry Schein, and Globus Medical Net Income description

Molina Healthcare Competitive Analysis

Molina Healthcare Competition Performance Charts

Five steps to successful analysis of Molina Healthcare Competition

Complement your Molina Healthcare position

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY